Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Broadpharm C12-200, 250 mg, Liquid, Branched-chain ionizable cationic lipidoid, Soluble in Ethanol, DMSO, DMF, CAS 1220890-25-4
Supplier: Broadpharm BP26474250MG
C12-200 is a branched-chain ionizable cationic lipidoid developed for efficient delivery in lipid nanoparticle (LNP) formulations. This product features five hydroxyl groups which allow for enhanced functionalization, making it suitable for intracellular delivery of therapeutic agents such as mRNA and siRNA. With significant improvements in formulation potency, including a notable 7-fold increase for erythropoietin-mRNA-loaded nanoparticles, C12-200 is essential for advancements in vaccine development and gene editing.
- Liquid form for ease of use
- Designed for lipid nanoparticle (LNP) formation
- Soluble in ethanol, DMSO, and DMF
- Stores at -20°C; protect from light
- Facilitates delivery of mRNA, siRNA, and proteins
- Provides opportunities for further chemical derivatization
- Significantly increases formulation potency
This item is not returnable.
View return policy
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?